Overview
Pharmaceutical technology company enhancing drug discovery with AI.
Founded
2014
Deals ยท 12mo
4
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Apex Intelligence | Sep 2026Led | $50 MSeed | |
Xellar Biosystems | Apr 2026Participated | $29 MSeries A | |
Leman Biotech | Mar 2026Led | $29 MSeries A | |
Signet Therapeutics | Jan 2026Participated | $11 MSeries A | |
GoFintech Innovation | Sep 2025Participated | $171 MOther Equity | |
ReviR Therapeutics | Jul 2024Participated | $30 MSeries A | |
Deep Principle | Jun 2024Participated | $10 MSeed | |
Leman Biotech | Feb 2023Participated | $10 MOther Equity | |
PhoreMost | Mar 2021Participated | $46 MSeries B | |
Apex Intelligence | Sep 2026Led | $50 MSeed | |
Xellar Biosystems | Apr 2026Participated | $29 MSeries A | |
Leman Biotech | Mar 2026Led | $29 MSeries A | |
Signet Therapeutics | Jan 2026Participated | $11 MSeries A | |
GoFintech Innovation | Sep 2025Participated | $171 MOther Equity | |
ReviR Therapeutics | Jul 2024Participated | $30 MSeries A | |
Deep Principle | Jun 2024Participated | $10 MSeed | |
Leman Biotech | Feb 2023Participated | $10 MOther Equity | |
PhoreMost | Mar 2021Participated | $46 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 1 |
| Series A | 1 | 3 |
| Series B | 0 | 1 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 1 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 7 |
| AI & Machine Learning | 3 |
| Crypto & Blockchain | 1 |
| Fintech | 1 |
| Real Estate & Construction | 1 |
| Space & Frontier Tech | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 2 |
| $25M-$50M | 4 |
| $50M-$100M | 1 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 4 |
| Europe | 3 |
| Hong Kong | 1 |
| China | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Tiantu Capital | 2 |
| 5Y Capital | 1 |
| Astellas Venture Management | 1 |
| BGF | 1 |
| CDH Investments | 1 |
| Charcot-Marie Tooth Research Foundation | 1 |
| Decent Capital | 1 |
| Green Pine Capital Partners | 1 |
| Guoshou Equity | 1 |
| IDG Capital | 1 |
| Inke | 1 |
| Lapam Capital | 1 |
| Legend Capital | 1 |
| Linear Capital | 1 |
| LinkX Capital | 1 |
| Mony Valley | 1 |
| Morningside Ventures | 1 |
| o2h Ventures | 1 |
| Parkwalk Advisors | 1 |
| SEE Fund | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 2 | 22% |
| Participating | 7 | 78% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 50% |
| Co-led | 1 | 50% |
Team
CSO & Board Member
Co-Founder and CEO
Co-Founder
COO, Head of US Operations
Founder
Senior Vice President of Business Strategy